Key result
Ondansetron administration in the PICU was associated with a corrected QT interval >500 ms in 11% of events, with risk increased by electrolyte abnormalities.
Why the study?
Does ondansetron administration prolong the corrected QT interval in pediatric ICU patients?
Cohort (n=107)
No
Does ondansetron administration prolong the corrected QT interval in pediatric ICU patients?
Ondansetron administration in critically ill pediatric patients is frequently associated with QT prolongation, particularly in those with baseline electrolyte abnormalities or organ dysfunction.
Answers are grounded in this paper and cite their sources.
May warrant QTc monitoring with ondansetron in PICU patients with electrolyte abnormalities; leaves open causal risk and practice implications.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Trivedi et al. (2016) conducted a cohort in Patients cared for in the PICU (n=107). Ondansetron was evaluated on Corrected QT interval > 500 ms. Ondansetron administration in the PICU was associated with a corrected QT interval >500 ms in 11% of events, with risk increased by electrolyte abnormalities.
Synapse has enriched 10 related papers. Consider them for comparative context: